Stage IVB Prostate Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Erdafitinib (DB12147)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04754425Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate CancerTreatment